Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,377,384    

Indirect Value

   $272,466,844      
Total Shares   50,534,882      
Total Value   $388,844,227      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $811,877 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $811,877 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-21 4 B $14.03 $52,789 I/I 3,763 15,681,851 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-07 4 B $14.10 $803,700 I/I 57,000 15,501,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-13 4 B $14.13 $162,508 I/I 11,500 15,636,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-07 4 B $14.38 $1,779,209 I/I 123,728 17,594,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-08 4 B $14.95 $1,683,400 I/I 112,602 17,706,978 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-06 4 B $15.96 $716,604 I/I 44,900 16,465,729 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 B $16.00 $320,000 D/D 20,000 20,000 3.92 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 B $16.00 $30,000,000 I/I 1,875,000 2,350,957 2.25 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-14 4 B $17.49 $664,498 D/D 37,993 1,675,572 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-27 4 B $17.79 $646,827 D/D 36,359 1,736,801 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-13 4 B $17.89 $355,922 D/D 19,895 1,637,579 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-17 4 B $17.89 $114,943 D/D 6,425 1,681,997 2.45 %
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2020-08-28 4 B $17.89 $467,555 D/D 26,135 1,762,936 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,555,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-27 4 B $17.91 $607,077 I/I 33,896 16,503,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-28 4 B $17.91 $676,998 I/I 37,800 16,541,176 2.25 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-24 4 B $17.93 $1,232,670 D/D 68,749 1,609,013 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,604,044 2.25 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-24 4 B $17.96 $197,991 D/D 11,024 1,700,342 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-21 4 B $17.97 $131,558 D/D 7,321 1,689,318 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-03 4 B $17.99 $697,256 I/I 38,758 16,594,058 2.25 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-27 4 B $17.99 $68,974 D/D 3,834 1,612,847 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-28 4 B $17.99 $73,849 D/D 4,105 1,616,952 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-30 4 B $17.99 $13,169 D/D 732 1,617,684 2.37 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-02-26 4 B $18.00 $67,518 I/I 3,751 16,469,480 2.25 %
  116  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us